Therapeutic Plasma Exchange in AChR-Ab Positive Generalized Myasthenia Gravis: A Real World Study About Its Early Response
Jiaxin Chen,1,2 Li Feng,1,2 Shiyin Li,2 Haiyan Wang,1,2 Xin Huang,1,2 Cunzhou Shen,1,2 Huiyu Feng1,2 1Department of Neurology and Neurointensive Care Unit, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China; 2Guangdong Provincial Key Laboratory of Diagn...
Saved in:
Main Authors: | Chen J (Author), Feng L (Author), Li S (Author), Wang H (Author), Huang X (Author), Shen C (Author), Feng H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
by: Antonino Lupica, et al.
Published: (2022) -
Autoantibody of NRIP, a novel AChR‐interacting protein, plays a detrimental role in myasthenia gravis
by: Li‐Kai Tsai, et al.
Published: (2021) -
Juvenile Generalized Myasthenia Gravis With AChR and MuSK Antibody Double Positivity: A Case Report With a Review of the Literature
by: XiuShan Ge, et al.
Published: (2022) -
Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review
by: Waheed W, et al.
Published: (2022) -
Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review [Erratum]
by: Waheed W, et al.
Published: (2022)